Interventional cardiology devices are medical devices which are introduced to treat the heart diseases. The most common type of heart disease is Coronary Heart Disease (CAD). It is a branch of cardiology that specifically deals with the catheter-based treatments such as an aneurysm, CAD, congenital heart defect, and others. Catheter performs the whole procedure by using fluoroscopy. Interventional cardiology provides the fast recovery, short hospital stay, reduces the complications, and controls the bleeding.
Middle East and Africa Interventional Cardiology Devices Market Size & Growth:
The Middle East and Africa interventional cardiology devices market are envisaged to reach USD XX Billion by 2024 from USD XX Billion in 2018, at a CAGR close to XX% during the forecast period. The key factors leading the interventional cardiology devices market are growing geriatric population, increasing prevalence of CAD, and technological advancements in interventional cardiology devices. The interventional cardiology market size is growing rapidly in emerging economies due to the technological advancements in cardiology. Stringent regulatory approvals and reimbursement issues are restraining the market growth during the forecast period. The advent of bioresorbable stents is creating opportunities for the interventional cardiology and peripheral vascular devices market which are more profitable. According to the reports by WHO (World Health Organization), the total death of people caused by CAD are nearly 11.5 Million. In addition, the rising demands for the minimally invasive surgeries are leading the market growth during the forecast period.
The Middle East and Africa Interventional Cardiology Devices Market Segments Share:
By considering the segmentation, the interventional cardiology devices market is categorised by product type, end-users, and geography. By product type, the market is classified into stents, catheters, interventional cardiology systems, PTCA (Percutaneous Transluminal Coronary Angioplasty), PTCA balloons, and others. Stents have taken up the majority interventional cardiology devices market share. Stents are again segmented into bare metal stents, drug-eluting, and bioresorbable stents. Among these, drug-eluting stents are holding the greater demand, owing to the higher efficiency of treatment, and reduces the in-stent restenosis. By geography, the market is segmented into the Asia Pacific, North America, Europe, South America, and the Middle East and Africa. By region, the Middle East and Africa region are segmented into Saudi Arabia, United Arab Emirates, and others.
The Middle East and Africa Interventional Cardiology Devices Market Trends:
- Cordis Corporation, a leading top player in interventional cardiology devices market, released MOZEC Rx PTCA Balloon Dilatation Catheter which indicates the stenotic portion of a coronary artery to improve the myocardial perfusion.
- NIRxcell Stent System is introduced by Cordis Corporation to improve coronary luminal diameter in patients.
The Middle East and Africa Interventional Cardiology Devices Market Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and Global Diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with major competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The major key players in the Middle East and Africa Interventional Cardiology Devices Market are:
- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic Inc.
- Cordis Corporation
- Terumo Corporation
- Johnson & Johnson
- Biosensors International Ltd
Along with these companies, there were many other companies considered/ cited in the report while analysing the Middle East and Africa interventional cardiology devices market. These companies hold substantial share-owning to the nature of the industry whereas rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and strong customer base.
1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1. Drivers
4.1.1. Increasing prevalence of Coronary Artery Disease (CAD)
4.1.2. Increasing demand for minimally invasive treatments
4.1.3. Technological advancements in interventional cardiology devices
4.1.4. Growing geriatric population
4.2. Restraints & Challenges
4.2.1. Reimbursement issues in emerging economies
4.2.2. Stringent regulatory approvals
4.3. Opportunities
4.3.1. Emergence of bioresorbable stents
4.3.2. Increasing Healthcare Expenditure in developing economies
5. Middle East and Africa Interventional Cardiology Devices Market– By Product Type
5.1. Stents
5.1.1. Bioresorbable Stents
5.1.2. Bare Metal Stents
5.1.3. Drug Eluting Stents
5.2. Catheters
5.2.1. Pulmonary Artery Catheters
5.2.2. IVUS (Intravascular Ultrasound Catheters)
5.2.3. PTCA (Percutaneous Transluminal Coronary Angioplasty) Guiding Catheters
5.2.4. Angiography Catheters
5.3. PTCA Balloons
5.3.1. Normal Balloons
5.3.2. Others
5.4. PTCA Guide Wires
5.5. Interventional Cardiology Systems
5.5.1. IVUS Systems
5.5.2. FFR (Fractional Flow Reserve) Systems
5.5.3. Optical Coherence Tomography (OCT) Systems
5.6. Others
6. Middle East and Africa Interventional Cardiology Devices Market- By End-users
6.1. Hospitals
6.2. Clinics
6.3. Ambulatory Surgical Centers
6.4. Others
7. Middle East and Africa Interventional Cardiology Devices Market– By Geography
7.1. Introduction
7.2. Middle East & Africa
7.2.1. Middle East
7.2.2. Africa
8. Middle East and Africa Interventional Cardiology Devices Market– Company Profiles
8.1. Abbott Laboratories
8.2. Boston Scientific Corporation
8.3. Medtronic Inc.
8.4. Cordis Corporation
8.5. Terumo Medical Corporation
8.6. Johnson & Johnson
8.7. Biosensors International Ltd
8.8. B. Braun Melsungen
8.9. Acrostak (Schweiz) AG
8.10. Biotronik
8.11. C.R. Bard
8.12. St. Jude Medical
8.13. Cardinal Health
8.14. IVascular
9. Middle East and Africa Interventional Cardiology Devices Market- Competitive Landscape
9.1. Market Share Analysis
9.2. Strategies Adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
10. Market Insights
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
11. Appendix
11.1. List of tables
11.2. List of figures
IND: (+91) 949418 5556
sales@envisionintelligence.com
Credibility and Transparency
Exhaustive Coverage
Competitive Edge
Golden Opportunities
Top-notch Reports Guaranteed
Post Purchase Support
